Sean T. Moriarty - Feb 15, 2024 Form 4 Insider Report for STEPAN CO (SCL)

Role
VP & GM Surfactants
Signature
/s/ Stephanie J. Pacitti, Attorney-in-Fact for Sean T. Moriarty
Stock symbol
SCL
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
4
Date filed
2/20/2024, 03:53 PM
Previous filing
Feb 16, 2024
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCL Common Stock Options Exercise +1.3K +12.07% 12.1K Feb 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCL Performance Shares Options Exercise -1.94K -100% 0 Feb 15, 2024 Common Stock 1.94K Direct F1
transaction SCL Performance Shares Disposed to Issuer $0 -2.73K -100% $0.00* 0 Feb 15, 2024 Common Stock 2.73K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023.
F2 Each performance share represents a contingent right to receive one share of Stepan Company common stock.
F3 The performance shares were forfeited due to Stepan Company's performance for the period ending December 31, 2023.